Racial and anthropometric differences in plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein-3

Urology

Volumn 66, Issue 3, 2005, Pages 587-592

  McGreevy, Katharine ^a   Hoel, Brian ^b   Lipsitz, Stuart ^b   Bissada, Nabil ^b   Hoel, David ^b  

^a NEW JERSEY DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TUMOR MARKER;

ADULT; AGE DISTRIBUTION; AGED; ANTHROPOMETRY; ARTICLE; BLOOD CHEMISTRY; BODY HEIGHT; CANCER RISK; CAUCASIAN; CHI SQUARE DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIGITAL RECTAL EXAMINATION; DISEASE MARKER; HUMAN; HUMAN EXPERIMENT; LINEAR REGRESSION ANALYSIS; MALE; NEGRO; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; SMOKING;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; ANTHROPOMETRY; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED;

EID: 24144454875     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2005.03.070     Document Type: Article

References (31)

1. J. Holly Insulin-like growth factor-I and new opportunities for cancer prevention Lancet 351 1998 1373 1375
2. M.N. Pollak, E.S. Schernhammer, S.E. Hankinson Insulin-like growth factors and neoplasia Nat Rev 4 2004 505 518
3. M. Pollak Insulin-like growth factor physiology and cancer risk Eur J Cancer 36 2000 1224 1228
4. H. Yu, T. Rohan Role of the insulin-like growth factor family in cancer development and progression J Natl Cancer Inst 92 2000 1472 1489
5. R. Rajah, B. Valentinis, P. Cohen Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism J Biol Chem 272 1997 12181 12188
6. A. Grimberg p53 and IGFBP-3 apoptosis and cancer protection Mol Genet Metab 70 2000 85 98
7. J.M. Chan, M.J. Stampfer, E. Giovannucci Plasma insulin-like growth factor-I and prostate cancer risk a prospective study Science 279 1998 563 566
8. P. Stattin, A. Bylund, S. Rinaldi Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk a prospective study J Natl Cancer Inst 92 2000 1910 1917
9. B. Djavan, B. Bursa, C. Seitz Insulin-like growth factor 1 (IGF-1), IGF-1 density, and IGF-1/PSA ratio for prostate cancer detection Urology 54 1999 603 606
10. A.P. Chokkalingam, M. Pollak, C.M. Fillmore Insulin-like growth factors and prostate cancer a population-based case-control study in China Cancer Epidemiol Biomarkers Prev 10 2001 421 427
11. C.S. Mantzoros, A. Tzonou, L.B. Signorello Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia Br J Cancer 76 1997 1115 1118
12. P. Stattin, S. Rinaldi, C. Biessy High levels of circulating insulin-like growth factor-I increase prostate cancer risk a prospective study in a population-based nonscreened cohort J Clin Oncol 22 2004 3104 3112
13. J.M. Chan, M.J. Stampfer, J. Ma Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer J Natl Cancer Inst 94 2002 1099 1106
14. Statistical Analysis Systems 1999 SAS Institute, Inc Cary, NC
15. E.A. Platz, M.N. Pollak, E.B. Rimm Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men Cancer Epidemiol Biomarkers Prev 8 1999 1107 1110
16. J.V. Tricoli, D.L. Winter, A.L. Hanlon Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancer Urology 54 1999 178 182
17. N.M. Wright, J. Renault, S. Willi Greater secretion of growth hormone in black than in white men possible factor in greater bone mineral density-a clinical research center study J Clin Endocrinol Metab 80 1995 2291 2297
18. K. DeLellis, S. Rinaldi, R. Kaaks Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3) the multiethnic cohort Cancer Epidemiol Biomarkers Prev 13 2004 1444 1451
19. D.L. Winter, A.L. Hanlon, S.L. Raysor Plasma levels of IGF-1, IGF-2, and IGFBP-3 in white and African-American men at increased risk of prostate cancer Urology 58 2001 614 618
20. V.G. Kaklamani, A. Linos, E. Kaklamani Age, sex, and smoking are predictors of circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 J Clin Oncol 17 1999 813 817
21. S. Teramukai, T. Rohan, H. Eguchi Anthropometric and behavioral correlates of insulin-like growth factor I and insulin-like growth factor binding protein 3 in middle-aged Japanese men Am J Epidemiol 156 2002 344 348
22. K. Landin-Wilhelmsen, L. Wilhelmsen, G. Lappas Serum insulin-like growth factor I in a random population sample of men and women relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin Clin Endocrinol 41 3 1994 351 377
23. D. Goodman-Gruen, E. Barrett-Connor Epidemiology of insulin-like growth factor-I in elderly men and women the Rancho Bernardo Study Am J Epidemiol 145 1997 970 976
24. T.B. Harris, D. Kiel, R. Roubenoff Association of insulin-like growth factor-I with body composition, weight history, and past health behaviors in the very old the Framingham Heart Study J Am Geriatric Soc 45 1997 133 139
25. A.V. Sarma, C.A. Jaffe, D. Schottenfeld Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index clinical correlates of prostate volume among black men Urology 59 2002 362 367
26. A.P. Chokkalingam, Y.T. Gao, J. Deng Insulin-like growth factors and risk of benign prostatic hyperplasia Prostate 52 2002 98 105
27. S.E. Oliver, B. Barrass, D. Gunnell Serum insulin-like growth factor I is positively associated with serum prostate-specific antigen in middle aged men without evidence of prostate cancer Cancer Epidemiol Biomarkers Prev 13 2004 163 165
28. A. Juul, P. Dalgaard, W.F. Blum Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation J Clin Endocrinol Metab 80 1995 2534 2542
29. L.B. Signorello, H. Kuper, P. Lagiou Lifestyle factors and insulin-like growth factor 1 levels among elderly men Eur J Cancer Prev 9 2000 173 178
30. Y. Ben-Shlomo, J. Holly, A. McCarthy An investigation of fetal, postnatal, and childhood growth with insulin-like growth factor I and binding protein 3 in adulthood Clin Endocrinol 59 2003 366 373
31. S. Chang, X. Wu, H. Yu Plasma concentrations of insulin like growth factors among healthy adult men and postmenopausal women associations with body composition, lifestyle, and reproductive factors Cancer Epidemiol Biomarkers Prev 11 2002 758 766